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Circulation: Cardiovascular Imaging
SPECIAL REPORT

SNMMI/ACR/ASNC/SCMR Joint
Credentialing Statement for Cardiac PET/MRI:
Endorsed by the American Heart Association
Terrence D. Ruddy; Mouaz Al-Mallah; James A. Arrighi; John P. Bois; David A. Bluemke; Marcelo F. Di Carli; Vasken Dilsizian;
Robert J. Gropler; Hossein Jadvar; Saurabh Malhotra; Matthier Pelletier-Galarneau; Thomas H. Schindler; Pamela K. Woodard;
Panithaya Chareonthaitawee *

BACKGROUND
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Founded in 1951, the Joint Commission, formally known
as the Joint Commission on Accreditation of Healthcare
Organizations and, previous to that, the Joint Commission
on Accreditation of Hospitals, is a United States-based
nonprofit organization that accredits more than 20,000
health-care organizations and programs in the United
States. The Joint Commission requires that there be a
credentialing system for delineating and granting privileges to every hospital physician. The Joint Commission
does not specify the qualifications. Privileges are generally practice-specific and are not usually transferable from
hospital to hospital. The granting of clinical privileges cannot and should not depend on a single criterion such as
board certification or membership in a particular specialty
society; other options, such as documented evidence of
requisite training, relevant experience, judgment skills,
and demonstrated current competence, should be available. It is the final responsibility of the hospital medical
staff and hospital governing board to ensure that a physician meets a reasonable standard of competency.
Positron emission tomography (PET)/magnetic resonance imaging (MRI) is an emerging complex hybrid
imaging modality recently introduced into clinical practice.
In June 2013, the American College of Radiology and
the Society of Nuclear Medicine and Molecular Imaging
charged a joint task force with developing a credentialing
statement for physicians responsible for the oversight and
interpretation of PET/MRI examinations. In conjunction
with the Cardiovascular Council of the Society of Nuclear

Medicine and Molecular Imaging, the task force has prepared this joint statement related to cardiac PET/MRI as
the third in a planned series of credentialing documents
covering all organ systems and clinical applications.1,2 The
first on PET/MRI of the brain was published in 2015.
This joint statement is intended to guide credentialing bodies that privilege physicians to oversee, supervise,
and interpret cardiac PET/MRI for patient care in the
United States.

DEFINITIONS
For the purposes of this statement, the following definitions apply:
MRI: A medical imaging technology that uses
high-strength magnetic fields to create high contrast
tomographic images. In cardiovascular imaging, MRI
techniques delineate anatomy of the heart and great
vessels. For cardiac imaging, special MRI sequences
with and without contrast enhancement and cardiac and
respiratory gating also provide soft-tissue characterization, accurate measurements of cardiac chamber size
and global and regional function, valvular morphology,
and physiologic parameters.
PET: A medical imaging technology that uses positron-emitting radiopharmaceuticals. The PET scanner detects high-energy annihilation photon pairs and
extrapolates the location of the original positron-emitting
atoms to create tomographic images of their biodistribution within the body. In cardiac imaging, this provides an
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assessment of the physiologic and functional processes
of the heart.
PET/MRI: A complex hybrid medical imaging technology that incorporates PET and MRI into a single
device. Such an imaging system allows either sequential acquisition (i.e., tandem back-to-back design) or
simultaneous acquisition (i.e., a PET insert in an MRI
gantry or an integrated PET/MRI design). In either
hybrid system, the goal is to combine PET and MRI
data for exact co-registration. For the purposes of this
document, a PET/MRI examination is defined as a full
diagnostic PET examination and a full diagnostic MRI
examination.
Radiopharmaceutical: A radioactive compound administered to patients for use in diagnosis and therapy.

APPLICATIONS FOR CARDIAC PET/MRI
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The following are examples of potential clinical or
research applications for PET/MRI of the heart3–7: rest
and/or stress myocardial perfusion, myocardial viability
including rest and/or stress perfusion when indicated,
inflammatory processes such as sarcoidosis and myocarditis, myocardial masses including non-neoplastic
and neoplastic (both primary and metastatic), infiltrative
processes such as amyloidosis, hereditary disorders
such as hypertrophic cardiomyopathy and AndersonFabry disease, cardiac valvular disorders and emerging
areas of research including tissue regeneration after
stem cell therapy, coronary artery plaque imaging and
assessment of sympathetic reinnervation after cardiac
transplant.

RESPONSIBILITIES OF PHYSICIANS
The physician or physicians supervising the examination must be responsible for all aspects of the cardiac
PET/MRI examination, such as reviewing indications
for the examination, prescribing the PET radiopharmaceutical and its activity, specifying the MRI pulse
sequences to be performed, prescribing the use and
dose of MRI contrast agents, confirming the quality
of the images appropriate for interpretation, interpreting the images, generating final reports, and ensuring
patient and personnel safety. A prescriber of radiopharmaceuticals must either be or work under a U.S.
Nuclear Regulatory Commission authorized user of
radioactive materials and comply with state regulations,
or hold the Canadian equivalent authorization. These
responsibilities may be distributed by expertise to two
physicians each credentialed, respectively, in MRI and
PET only.
With regard to supervision and interpretation of
cardiac PET/MRI, physicians may best participate

Joint Credentialing Statement for Cardiac PET/MRI

in their practice according to their special interests
and qualifications in nuclear medicine and molecular imaging, nuclear cardiology, multimodality cardiac imaging, or related practice paradigms.8–10 It
is recognized that variations in the local regulatory
requirements for practices and individual-physician
qualifications may of necessity dictate site-specific
practice patterns. For example, in certain clinical settings, it may be beneficial for 2 physicians to interpret
cardiac PET/MRI examinations together, with one
primarily interpreting the PET component and other
primarily interpreting the MRI component. Nevertheless, the interpreters should meet the credentialing
criteria for the modality for which they are providing
a primary interpretation. The 2 physicians must reach
consensus regarding the final interpretation of the
combined PET/MRI findings to issue a joint PET/
MRI report (1 billing physician of record) or 2 separate correlative PET/MRI reports. Simple numeric
criteria are not an optimal measure of competency.
Documentation of competency by the use of objective,
outcome-based tools related to clinical experience is
preferable. The criteria detailed in Table 1 may be used
for guidance.
The recommendations for PET/MRI practice set
forth in this document have been developed in consideration of the complex nature of this emerging hybrid
modality and with reference to published practice
parameters, procedure guidelines, and credentialing
statements.
The practice of cardiac PET/MRI requires a solid
knowledge base of PET techniques and MRI techniques. Although the goal is mastery of simultaneously acquired cardiac PET/MRI examinations, the
physician’s education, training, and experience should
encompass dedicated cardiac PET, cardiac PET/
computed tomography (CT), and dedicated cardiac
MRI. Fundamentals include familiarity with technical
parameters (protocols, contrast agents, sequences,
processing) as well as biologic and clinical parameters (anatomy, physiology, normal variants, disease
states).
It is recognized that both general radiology and cardiovascular training programs vary widely in their ability
to provide experience in cardiac PET or cardiac MRI.
Thus, whether a physician comes from a radiology,
nuclear medicine, or cardiology training background,
gaps in experience may be present after formal training. This writing committee therefore recommends that
the credentialing standards for cardiac PET/MRI be the
same irrespective of the primary specialty of the physician (radiology, nuclear medicine, or cardiology). This
writing committee also recommends that the cardiology or radiology trainee wishing to gain competency in
independent interpretation of cardiac PET/MRI have

Circ Cardiovasc Imaging. 2022;15:e014576. DOI: 10.1161/CIRCIMAGING.122.014576

August 2022

629

Ruddy et al

Joint Credentialing Statement for Cardiac PET/MRI

Table 1. Initial and Continuing Competency Criteria for Credentialing Physicians to Independently Practice Cardiac PET/MRI
Number of interpretations (training)

Didactic requirement

Number of interpretations
(continuing)

CME/MOC

100 cardiac PET examinations (applicant must be physically present and perform initial interpretation of 50 of
these)*; Board certification† or equivalent; radiation
safety training for NRC 35.290 imaging and localization
studies (or equivalent)

20 h of didactic education is
recommended

100 cardiac PET studies within
prior 3 years‡

Fulfilling MOC; or 15 h CME related to cardiac PET in prior 3 years

100 cardiac MRI examinations (applicant must be physically present and perform initial interpretation of 50 of
these)*; Board certification † or equivalent

20 h of didactic education is
recommended

100 cardiac MRI within prior
3 years‡

Fulfilling MOC; or 15 h CME related to cardiac MRI in prior 3 years

An alternative and acceptable method of performance of the cardiac PET/MRI examination is supervision and interpretation by two physicians, each credentialed
individually in either cardiac PET or cardiac MRI.
*For programs with hybrid cardiac PET/MRI, combined cardiac PET/MRI examinations may count for both cardiac PET and cardiac MRI examinations. “Physical presence” implies involvement on acquisition and processing of studies.
†American Board of Radiology (ABR), American Board of Nuclear Medicine (ABNM), Certification Board of Nuclear Cardiology or the Certification Board of Cardiovascular Magnetic Resonance, or the equivalent in Canada.
‡For those pursuing credentials in pediatric cardiac PET/MRI, given the relatively low number of pediatric PET and MRI studies, an exception should be made that
would allow for the continuing training to be more than 3 years, in order to achieve the competency criteria. A timeframe of 5 years may be reasonable, but in certain
specialized clinical settings where the practice is limited only to pediatrics, the proposed criteria may be waived.
CME indicates continuing medical education; MOC, maintenance of certification; MRI, magnetic resonance imaging; NRC, Nuclear Regulatory Commission; and PET,
positron emission tomography.
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concurrent or prior training in cardiac PET and cardiac
MRI as outlined in Table 1.
For those with radiology or nuclear medicine as a
primary specialty wishing to interpret cardiac PET/
MRI in clinical practice, this writing committee recommends that in addition to the recommended initial
training and continuing requirements, the radiologists
or nuclear medicine specialist also holds and maintains
certification by the American Board of Radiology or
the American Board of Nuclear Medicine, respectively,
or the equivalent in Canada. For those with cardiology as a primary specialty wishing to interpret cardiac
PET/MRI in clinical practice, this writing committee
recommends that in addition to the recommended
initial training and continuing requirements, that the
cardiologist also hold a certificate by either the Certification Board of Nuclear Cardiology or the Certification
Board of Cardiovascular Magnetic Resonance, or the
equivalent in Canada.
The training in cardiac PET/MRI should be based
on acquisition of competencies, and not number of procedures alone. Training must also account for baseline
differences in knowledge; trainees from a cardiologybased background, for example, may begin with a more
advanced understanding of cardiac anatomy and physiology, whereas those from a radiology background may
begin with a more comprehensive understanding of
instrumentation.
The recommendations set forth include, first, a firsthand review and supervised interpretation of hybrid
cardiac PET/MRI or separately acquired PET and MRI
examinations, recognizing that hybrid cardiac PET/
MRI training experiences are currently unlikely to
be widely available, and second, didactic educational
hours in the basic science and clinical applications of
each modality.

QUALIFICATIONS OF PHYSICIANS
RESPONSIBLE FOR CARDIAC PET/MRI—
INITIAL COMPETENCY
All physicians assuming responsibility for independent practice of cardiac PET/MRI should meet the categories for
initial competency outlined in Table 1. This table defines the
number and time-based criteria that are generally required
to ensure sufficient exposure to the range, volume, and
diversity of clinical experience necessary for competency.
Ultimately, determination of whether an individual has the
requisite knowledge and skill for independent practice of
cardiac PET/MRI should be based on a formal assessment
of competency. Those considering these thresholds should
bear in mind that numbers of procedures are proxies for
acquiring the technical proficiency and analytic skills essential for clinical mastery of an imaging technique. An alternative and acceptable method of performance of the cardiac
PET/MRI examination is supervision and interpretation by
two physicians, each credentialed individually in either cardiac PET or cardiac MRI, respectively.

Clinical Experience/Supervised Interpretations
Cases must include broad representation of the types of
cardiac examinations, indications, available radiopharmaceuticals, and contrast agents that are encountered typically in clinical practice. For trainees (residents or fellows)
who are currently in training programs, documented cases
with direct participation of the trainee and appropriate
supervision by attending physicians experienced in cardiac PET/MRI is preferred. Cases presented in specifically
designed society or organization approved case-based
conferences or courses, live or online, are acceptable. Of
note, hybrid cardiac PET/MRI cases may be counted in
each appropriate category to fulfill the recommendations.
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Didactic Education Hours

APPROVAL

Didactic education should supplement case-based conferences used to achieve the number of supervised interpretations and should include physics relevant to cardiac
PET and cardiac MRI, use of MRI contrast agents, MRI
safety, radiation safety of PET radiopharmaceuticals, and
issues relevant to hybrid cardiac PET/MRI.

This credentialing statement was approved by the American College of Radiology Executive Committee of the
Board of Chancellors on March 3, 2021, the Society for
Cardiovascular Magnetic Resonance in February 2021,
the American Heart Association on October 27, 2021, the
American Society of Nuclear Cardiology Board of Directors on November 30, 2021, and the Society of Nuclear
Medicine and Molecular Imaging Board of Directors on
January 28, 2022.

Training for Authorized Use of
Radiopharmaceuticals for Imaging and
Localization Studies
Training for physicians who intend to practice in the
United States must satisfy Nuclear Regulatory Commission requirements for training in imaging and localization
studies (10 CFR 35.290).

QUALIFICATIONS OF PHYSICIANS
RESPONSIBLE FOR CARDIAC PET/MRI—
CONTINUING COMPETENCY
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Physicians assuming responsibility for independent practice of cardiac PET/MRI should meet competency in
both cardiac PET and cardiac MRI as outlined in Table 1.
An alternative and acceptable method of interpretation
of the cardiac PET/MRI examination is interpretation by
two individuals, each with competency in one of the two
complementary modalities.

Clinical Experience/Supervised Interpretations
Cases must include broad representation of the types
of examinations, indications, available radiopharmaceuticals, and contrast agents that are encountered typically in clinical practice. Direct participation
in clinical cases should include involvement in all
aspects of examination. Objective documentation of
direct participation should be kept by each physician.
Cases presented in specifically designed society or
organization approved case-based conferences or
courses, live or online, may be used to supplement
ongoing experience, particularly for unusual cases
that are typically encountered infrequently in clinical
practice. Of note, hybrid cardiac PET/MRI cases may
be counted in each appropriate category to fulfill the
recommendations.
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